Alpha-caine Gel
NDC Package 55346-2902-1

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Alpha-caine (benzocaine) gel is do not exceed recommended dosage.adults and children 2 years of age and older: apply to affected area. This formulation utilizes a gel delivery system. Marketed by Dental Technologies, Inc., this product is identified by NDC 55346-2902 and is authorized under FDA application M022.

Identification & Billing

NDC Package Code
55346-2902-1
Package Description
30 g in 1 BOTTLE, PLASTIC
Product Code
55346-2902
11-Digit Billing Format
55346290201
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Alpha-caine Topical Anesthetic
Non-Proprietary Name
Benzocaine
Substance Name
Benzocaine
Dosage Form
Gel - A semisolid3 dosage form that contains a gelling agent to provide stiffness to a solution or a colloidal dispersion.4 A gel may contain suspended particles.
Administration Route
  • Dental - Administration to a tooth or teeth.
  • Periodontal - Administration around a tooth.
Active Ingredient(s)
BENZOCAINE 200 mg/g
Pharmacologic Class
Usage Information
Do not exceed recommended dosage.adults and children 2 years of age and older: apply to affected area. Gargle, swish around in the mouth, or allow to remain in place at least 1 minute and then spit out. Use up to 4 times daily or as directed by dentist or doctor. children under 12 years of age: should be supervised in the use of the product. children under 2 years of age: do not use

Regulatory & Marketing

Labeler Name
Dental Technologies, Inc.
Product Type
Human Otc Drug
FDA Application #
M022
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
12-31-1999
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 55346-2902-1 identifies a specific commercial package of 30 g in 1 bottle, plastic of Alpha-caine Topical Anesthetic, a human over the counter drug labeled by Dental Technologies, Inc.. This gel is formulated for dental; periodontal use and contains benzocaine as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Dental Technologies, Inc. on December 31, 1999. The current certification is valid through December 31, 2026.

How is this Dental Technologies, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 55346290201. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
55346-2902-1
11-Digit CMS (5-4-2)
55346-2902-01

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.